Tenofovir disoproxil fumarate

Details:

Tenofovir disoproxil fumarate (CAS No.: 202138-50-9) 1. Name: tenofovir disoproxil fumarate 2. CAS No: 147127-20-6 3. MF: C9H14N5O4P 4. Use: anti-HIV 5. Appearance: white crystals Product Name Tenofovir disoproxil fumarate Synonyms 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate Molecular Formula C19H30N5O10P.C4H4O4 Molecular Weight 635.51 CAS Registry Number 405165-61-9 Appearance White crystalline powder or solid Puirty NLT98% Specification Enterprise Standard Molecular Structure1. Name tenofovir disoproxil fumarate 2. CAS No 147127-20-6 3. MF C9H14N5O4P 4. Use anti-HIV 5. Appearance white CAS No 147127-20-6 MF C23H34N5O14PUse anti-HIV Appearance white crystals Characteristics almost white crystalline Melting point 113 to 118°C Rotation -13 to 18°C Loss on drying ≤5.0% Contains ≥99 to 101% Molecular weight 635.51CAS registry number 405165-61-9Appearance white crystalline powder or solid Purity NLT98%Specification enterprise standardMolecular structure       Product NameTenofovir disoproxil fumarateSynonyms  9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate     Molecular Formula  C19H30N5O10P.C4H4O4Molecular Weight635.51CAS Registry Number405165-61-9AppearanceWhite crystalline powder or solidPuirtyNLT98%SpecificationEnterprise Standard  Molecular Structure  Packing Factory   introduction Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts in controlled studies of tenofovir in treatment-naïve and treatment-experienced adults. There are no study results demonstrating the effect of tenofovir on the clinical progression of HIV.1. Name tenofovir disoproxil fumarate 2. CAS No 147127-20-6 3. MF C9H14N5O4P 4. Use anti-HIV 5. Appearance white CAS No 147127-20-6 MF C23H34N5O14PUse anti-HIV Appearance white crystals Characteristics almost white crystalline Melting point 113 to 118°C Rotation -13 to 18°C Loss on drying ≤5.0% Contains ≥99 to 101% Molecular weight 635.51CAS registry number 405165-61-9Appearance white crystalline powder or solid Purity NLT98%Specification enterprise standardMolecular structure       Product NameTenofovir disoproxil fumarateSynonyms  9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate     Molecular Formula  C19H30N5O10P.C4H4O4Molecular Weight635.51CAS Registry Number405165-61-9AppearanceWhite crystalline powder or solidPuirtyNLT98%SpecificationEnterprise Standard  Molecular Structure  Packing Factory   introduction Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts in controlled studies of tenofovir in treatment-naïve and treatment-experienced adults. There are no study results demonstrating the effect of tenofovir on the clinical progression of HIV. It also has activity against wild-type and lamivudine-resistant HBV.